Home / Going-concern warnings / NEUROONE MEDICAL TECHNOLOGIES Corp
Filed 2026-08-13 路 Form 10-Q 路 Accession 0001213900-26-088724 nano
Price before filing: $1.52 (2026-08-12 close, split/dividend-adjusted)
Market cap at flag: $15.9M (2026-08-13) 路 Latest: $8.3M (2026-10-16)
| Window | NMTC | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -1.3% | -1.5% | +0.2% | 2026-09-14 |
| 90 days | pending | pending | until 2026-11-11 | |
| 180 days | pending | pending | until 2027-02-09 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider sold $32K (1 sale)
30 days after: 1 insider bought $67K (1 purchase)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Christianson Mark Market Development Director | Sale | 10,000 | $3.18 | $32K | no | Form 4 |
| 2026-08-13: red flag filed | |||||||
| 2026-08-27 | Wambeke David J. Chief Business Officer | Purchase | 33,333 | $2.01 | $67K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-05-15 to 2026-09-12. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-06-30)
Why this score: quarterly (unaudited) disclosure; also within 90 days: Non-reliance / restatement
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.